Weekly Top Insider Buys: IBM, BAC, SPG, HES, VRX
The overall trend of insiders is illustrated in the chart below:
International Business Machines (IBM): Director David N. Farr Bought 1,108 Shares
Director of International Business Machines, David N. Farr, bought 1,108 shares on 05/14/2012 at an average price of $196. International Business Machines uses advanced information technology to provide customer solutions. International Business Machines has a market cap of $233.09 billion; its shares were traded at around $196 with a P/E ratio of 14.5 and P/S ratio of 2.2. The dividend yield of International Business Machines stocks is 1.7%. International Business Machines had an annual average earnings growth of 11.8% over the past 10 years. GuruFocus rated International Business Machines the business predictability rank of 4.5-star.
On April 17, IBM announced first-quarter 2012 diluted earnings of $2.61 per share, compared with diluted earnings of $2.31 per share in the first quarter of 2011, an increase of 13 percent. First-quarter net income was $3.1 billion compared with $2.9 billion in the first quarter of 2011, an increase of 7 percent. Operating (non-GAAP) net income was $3.3 billion compared with $3.0 billion in the first quarter of 2011, an increase of 9 percent. Total revenues for the first quarter of 2012 of $24.7 billion were flat (up 1 percent, adjusting for currency) from the first quarter of 2011.
Last week, Director David N Farr bought 1,108 shares of IBM stock. Senior Vice President Michael D. Rhodin and Senior Vice President John E. Kelly III sold shares this year. Senior Vice President and CFO Mark Loughridge sold 29,449 shares in February.
Bank of America Corp. (BAC): Director Donald E. Powell Bought 19,500 Shares
Director of Bank of America Corp., Donald E. Powell, bought 19,500 shares during the past week at an average price of $6.97. Bank of America Corp. is one of the world's financial services companies. Bank of America Corp. has a market cap of $81.44 billion; its shares were traded at around $6.97 with and P/S ratio of 0.7. The dividend yield of Bank of America Corp. stocks is 0.5%.
On April 19, Bank of America Corporation reported net income of $653 million, or $0.03 per diluted share, for the first quarter of 2012. Revenue, net of interest expense, on a fully taxable-equivalentbasis was $22.5 billion. The results compare to net income of $2.0 billion, or $0.17 per diluted share, in the year-ago quarter on revenue of $27.1 billion when the company reported negative valuation adjustments of $943 million, or $0.06 per share.
This month, Director Donald E. Powell bought 22,000 shares of BAC stock.
Simon Property Inc. (SPG): Director Larry C. Glasscock Bought 1,200 Shares
Director of Simon Property Group Inc., Larry C. Glasscock, bought 1,200 shares on 5/10/2012 at an average price of $144.34. Simon Property Group Inc. is a self-administered and self-managed real estate investment trust which, through its subsidiary partnerships, is engaged in the ownership, development, management, leasing, acquisition and expansion of income-producing properties, primarily regional malls and community shopping centers. Simon Property Group Inc. has a market cap of $46.47 billion; its shares were traded at around $144.34 with a P/E ratio of 22 and P/S ratio of 10.8. The dividend yield of Simon Property Group Inc. stocks is 2.4%. Simon Property Group Inc. had an annual average earnings growth of 3.1% over the past 10 years.
On April 27, Simon Property Group Inc. reported results for the quarter ended March 31, 2012. Net income attributable to common stockholders was $645.4 million, or $2.18 per diluted share, as compared to $179.4 million, or $0.61 per diluted share, in the prior year period. The increase on a per share basis was 257.4%.
Last week, Director Larry C. Glasscock bought 1,200 shares. Director Karen N. Horn sold 3,168 shares in March. Senior Vice President and Chief Accounting Officer Steven K. Broadwater sold 1,010 shares in February. Executive Vice President/President Simon Management Group John Rulli and Chairman Emeritus of the Board Herbert Simon sold shares in December.
Hess Corp (HES): Director Metzsch Ernst H. Von Bought 20,000 Shares
Director of Hess Corp, Metzsch Ernst H. Von, bought 20,000 shares on 5/16/2012 at an average price of $44.6. Hess Corporation, is a global integrated energy company engaged in the exploration for and the production, purchase, transportation and sale of crude oil and natural gas, as well as the production and sale of refined petroleum products, electricity. Hess Corp. has a market cap of $16.38 billion; its shares were traded at around $44.6 with a P/E ratio of 8.6 and P/S ratio of 0.4. The dividend yield of Hess Corp stocks is 0.8%. Hess Corp had an annual average earnings growth of 7.2% over the past 10 years.
On April 25, Hess Corporation reported net income of $545 million for the first quarter of 2012 compared with $929 million for the first quarter of 2011. Exploration and Production earnings were $635 million in the first quarter of 2012 compared with $797 in the first quarter of 2011.
This month, Director Metzsch Ernst H. Von and Director John H. Mullin III bought shares of HES stock. Chairman of the Board and CEO, 10% Owner John B Hess bought 48,000 shares in April. Director Risa J. Lavizzo-mourey, Director Frank Albert Olson, and Director Edith E. Holiday bought shares in March.
Valeant Pharmaceuticals International Inc. (VRX): Executive Vice President Administration and CHCO Brian M. Stolz Bought 5,000 Shares
Executive Vice President Administration and CHCO of Valeant Pharmaceuticals International Inc., Brian M. Stolz, bought 5,000 shares on 5/10/2012 at an average price of $47.1. Valeant Pharmaceuticals International Inc. is a pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics. Valeant Pharmaceuticals International Inc. has a market cap of $16.23 billion; its shares were traded at around $47.1 with a P/E ratio of 15.9 and P/S ratio of 6.6.
On May 3, Valeant Pharmaceuticals Inc. reported a net loss of $12.9 million for the first quarter of 2012, or $0.04 per diluted share. On an adjusted Cash EPS basis, adjusted income was $360.3 million, or $1.14 per diluted share. Excluding the divestiture of the dermatology products, adjusted income was $311.8 million, or $0.99 per diluted share.
This month, Director Laurence E. Paul, ValueAct Holdings LP, and Executive Vice President Administration and CHCO Brian M. Stolz bought shares of VRX stock. CFO Howard Bradley Schiller bought 9,200 shares in March; President and COO, Valeant International BB Richard Kevin Masterson sold 4 shares this month.
For the complete list of stocks that were bought by their company executives, go to: Insider Buys.